Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapy
✍ Scribed by Fjiuth, Jacek; Chauvet, Bruno; Vincent, Pascal; Félix-Faure, Caroline; Reboul, François
- Book ID
- 122059929
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 197 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr